P Dore, R Robert, G Grollier, J Rouffineau, H Lanquetot, JM Charriere and JL Fauchere
Service de Pneumologie, Centre Hospitalier Regional et Universitaire de Poitiers, France.

The role of anaerobic bacteria in ventilator-associated pneumonia (VAP) has been little investigated. In this study we analyzed the incidence of anaerobes in patients with a first episode of bacteriologically documented VAP (> 10(3)CFU/ml), using protected specimen brushes (PSB). We particularly took care to preserve anaerobic conditions during transport and the microbiological procedure. Two groups were considered: group A with anaerobic bacteria recovered from PSB, with or without anaerobes, and group B with aerobic bacteria only. One hundred and thirty patients were included, 30 (23%) in group A, and 100 (77%) in group B. The main anaerobic strains isolated were Prevotella melaninogenica (36%), Fusobacterium nucleatum (17%), and Veillonella parvula (12%). Univariate analysis demonstrated that patients in group A were younger than those in group B (p < 0.05) and their simplified acute physiologic score was higher (p < 0.02). The percentage of patients receiving antibiotics before PSB did not differ significantly between group A (57%) and group B (35%). VAP with anaerobes occurred more often in patients orotracheally intubated than nasotracheally intubated (p < 0.02). Episodes of VAP involving anaerobic bacteria occurred more often in the first five days (early VAP) than after the fifth day (late VAP) (p < 0.05). The 3-mo mortality rate was similar in the two groups, but death occurred earlier in group B (p < 0.01). Multivariate analysis demonstrated that presence of altered level of consciousness (p = 0.0002), higher simplified acute physiologic score (p = 0.003), and admission to the medical ICU (p = 0.02) were the factors independently predisposing to the development of VAP with anaerobes.

This article has been cited by other articles:

				M. M. Tunney, T. R. Field, T. F. Moriarty, S. Patrick, G. Doering, M. S. Muhlebach, M. C. Wolfgang, R. Boucher, D. F. Gilpin, A. McDowell, et al. Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis Am. J. Respir. Crit. Care Med., May 1, 2008; 177(9): 995 - 1001. [Abstract] [Full Text] [PDF]

				F. K. Bahrani-Mougeot, B. J. Paster, S. Coleman, S. Barbuto, M. T. Brennan, J. Noll, T. Kennedy, P. C. Fox, and P. B. Lockhart Molecular Analysis of Oral and Respiratory Bacterial Species Associated with Ventilator-Associated Pneumonia J. Clin. Microbiol., May 1, 2007; 45(5): 1588 - 1593. [Abstract] [Full Text] [PDF]

				K. A. Davis Ventilator-associated pneumonia: a review. J Intensive Care Med, July 1, 2006; 21(4): 211 - 226. [Abstract] [PDF]

				G. W. Soo Hoo, Y. E. Wen, T. V. Nguyen, and M. B. Goetz Impact of Clinical Guidelines in the Management of Severe Hospital-Acquired Pneumonia Chest, October 1, 2005; 128(4): 2778 - 2787. [Abstract] [Full Text] [PDF]

				Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia Am. J. Respir. Crit. Care Med., February 15, 2005; 171(4): 388 - 416. [Full Text] [PDF]

				G. Hoffken and M. S. Niederman Nosocomial Pneumonia: The Importance of a De-escalating Strategy for Antibiotic Treatment of Pneumonia in the ICU Chest, December 1, 2002; 122(6): 2183 - 2196. [Abstract] [Full Text] [PDF]

				J. Chastre and J.-Y. Fagon Ventilator-associated Pneumonia Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 867 - 903. [Abstract] [Full Text] [PDF]

				J. Rello, J. A. Paiva, J. Baraibar, F. Barcenilla, M. Bodi, D. Castander, H. Correa, E. Diaz, J. Garnacho, M. Llorio, et al. International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia Chest, September 1, 2001; 120(3): 955 - 970. [Abstract] [Full Text] [PDF]

				D. Dreyfuss, L. Mier, T. E. Finucane, C. Christmas, I. Campbell-Taylor, and P. Marik Aspiration Pneumonia N. Engl. J. Med., June 14, 2001; 344(24): 1868 - 1870. [Full Text] [PDF]

				R. S. Morehead and S. J. Pinto Ventilator-Associated Pneumonia Arch Intern Med, July 10, 2000; 160(13): 1926 - 1936. [Abstract] [Full Text] [PDF]

				R. Robert, G. Grollier, M. Hira, and P. Dore A Role for Anaerobic Bacteria in Patients With Ventilatory Acquired Pneumonia : Yes or No? Chest, April 1, 2000; 117(4): 1214 - 1215. [Full Text] [PDF]

				M. H. Kollef Antimicrobial Therapy of Ventilator-Associated Pneumonia : How To Select an Appropriate Drug Regimen Chest, January 1, 1999; 115(1): 8 - 11. [Full Text] [PDF]

				P. E. Marik and P. Careau The Role of Anaerobes in Patients With Ventilator-associated Pneumonia and Aspiration Pneumonia: A Prospective Study Chest, January 1, 1999; 115(1): 178 - 183. [Abstract] [Full Text] [PDF]